BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/9/2015 5:57:00 PM | Browse: 1040 | Download: 1400
 |
Received |
|
2015-06-01 18:15 |
|
Peer-Review Started |
|
2015-06-05 10:17 |
|
To Make the First Decision |
|
2015-09-09 17:01 |
|
Return for Revision |
|
2015-09-13 13:44 |
|
Revised |
|
2015-09-25 11:57 |
|
Second Decision |
|
2015-10-22 18:24 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2015-10-26 17:56 |
|
Articles in Press |
|
2015-10-26 17:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-11-27 14:52 |
|
Publish the Manuscript Online |
|
2015-12-09 17:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hiroyuki Kato, Hideo Yoshida, Hiroyoshi Taniguch, Ryutaro Nomura, Kengo Sato, Ichiro Suzuki and Ryo Nakata |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hiroyuki Kato, MD, Department of Gastroenterology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-8935, Japan. hiroyuki.kato.911@gmail.com |
| Key Words |
Hepatocellular carcinoma; Stereotactic body radiotherapy; Cyberknife; Neoplasm metastasis/therapy; Liver radiotherapy |
| Core Tip |
Due to an aging of hepatocellular carcinoma (HCC) patient population, a growing number of patients are ineligible for conventional therapy. The Cyberknife system delivers stereotactic body radiation therapy (SBRT), which offers minimally invasive treatment with high doses of radiation. There has been an increase in the number of successful reports of using SBRT against liver-confined HCC. We found that the Cyberknife can safely be administered even in patients with advanced or terminal stage HCC. Our results suggest that SBRT may have the potential to increase the overall survival for advanced stage HCC patients. High alpha fetoprotein levels were associated with worse survival, but a higher radiation dose improved the survival. |
| Publish Date |
2015-12-09 17:57 |
| Citation |
Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol 2015; 21(46): 13101-13112 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i46/13101.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i46.13101 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
